Indivior reported 779M in Current Liabilities for its fiscal semester ending in March of 2026.





Current Liabilities Change Date
AstraZeneca USD 31.55B 1.02B Jun/2026
Cassava Sciences USD 40.11M 3.72M Mar/2026
GlaxoSmithKline GBP 21.53B 895M Jun/2026
Glaxosmithkline GBP 22.43B 6.39B Mar/2026
Hikma Pharmaceutical USD 1.45B 603M Dec/2025
Roche Holding CHF 28.85B 846M Jun/2026
West Pharmaceutical Services USD 640.5M 33.5M Jun/2026